These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Infliximab for the treatment of fistulas in patients with Crohn's disease. Present DH; Rutgeerts P; Targan S; Hanauer SB; Mayer L; van Hogezand RA; Podolsky DK; Sands BE; Braakman T; DeWoody KL; Schaible TF; van Deventer SJ N Engl J Med; 1999 May; 340(18):1398-405. PubMed ID: 10228190 [TBL] [Abstract][Full Text] [Related]
4. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease. Lichtenstein GR; Yan S; Bala M; Blank M; Sands BE Gastroenterology; 2005 Apr; 128(4):862-9. PubMed ID: 15825070 [TBL] [Abstract][Full Text] [Related]
5. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis. Keating GM; Perry CM BioDrugs; 2002; 16(2):111-48. PubMed ID: 11985485 [TBL] [Abstract][Full Text] [Related]
6. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn's disease: results from the ACCENT II study. Sands BE; Blank MA; Diamond RH; Barrett JP; Van Deventer SJ Aliment Pharmacol Ther; 2006 Apr; 23(8):1127-36. PubMed ID: 16611273 [TBL] [Abstract][Full Text] [Related]
7. Infliximab in treatment of Crohn's disease: the Milan experience. Ardizzone S; Colombo E; Maconi G; Bollani S; Manzionna G; Petrone MC; Bianchi Porro G Dig Liver Dis; 2002 Jun; 34(6):411-8. PubMed ID: 12132788 [TBL] [Abstract][Full Text] [Related]
8. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience. Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431 [TBL] [Abstract][Full Text] [Related]
9. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Poritz LS; Rowe WA; Koltun WA Dis Colon Rectum; 2002 Jun; 45(6):771-5. PubMed ID: 12072629 [TBL] [Abstract][Full Text] [Related]
10. Clinical and radiological responses after infliximab treatment for perianal fistulizing Crohn's disease. Rasul I; Wilson SR; MacRae H; Irwin S; Greenberg GR Am J Gastroenterol; 2004 Jan; 99(1):82-8. PubMed ID: 14687146 [TBL] [Abstract][Full Text] [Related]
12. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Angelucci E; Cocco A; Viscido A; Caprilli R Inflamm Bowel Dis; 2008 Mar; 14(3):435-6. PubMed ID: 18050300 [No Abstract] [Full Text] [Related]
13. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Hanauer SB; Feagan BG; Lichtenstein GR; Mayer LF; Schreiber S; Colombel JF; Rachmilewitz D; Wolf DC; Olson A; Bao W; Rutgeerts P; Lancet; 2002 May; 359(9317):1541-9. PubMed ID: 12047962 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Van Assche G; Vanbeckevoort D; Bielen D; Coremans G; Aerden I; Noman M; D'Hoore A; Penninckx F; Marchal G; Cornillie F; Rutgeerts P Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051 [TBL] [Abstract][Full Text] [Related]
15. Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice. Cadahia V; García-Carbonero A; Vivas S; Fuentes D; Niño P; Rebollo P; Rodrigo L Rev Esp Enferm Dig; 2004 Jun; 96(6):369-74; 374-8. PubMed ID: 15230666 [TBL] [Abstract][Full Text] [Related]
16. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands. de Ridder L; Escher JC; Bouquet J; Schweizer JJ; Rings EH; Tolboom JJ; Houwen RH; Norbruis OF; Derkx BH; Taminiau JA J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):46-52. PubMed ID: 15187780 [TBL] [Abstract][Full Text] [Related]
18. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
19. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine. Schröder O; Blumenstein I; Schulte-Bockholt A; Stein J Aliment Pharmacol Ther; 2004 Feb; 19(3):295-301. PubMed ID: 14984376 [TBL] [Abstract][Full Text] [Related]
20. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Sandborn WJ; Hanauer SB Am J Gastroenterol; 2002 Dec; 97(12):2962-72. PubMed ID: 12492177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]